Şunu aradınız:: naive (İngilizce - Maltaca)

mtx-naive
qatt ma Ħadu mtx

naive patients
pazjenti li qatt ma ħadu infliximab plaċebo trudexa trudexa

methotrexate-naive
qatt ma Ħadu methotrexate

infliximab naive patients
pazjenti li kienu diġà ħadu infliximab qabel plaċebo trudexa

in antiretroviral naive patients
f’pazjenti li qatt ma ngħataw antiretrovirali

sqv naive/experienced population
popolazzjoni li qatt ma Ħadu sqv qabel/b’esperjenza ta’ sqv

previously insulin naive patients
pazjenti li qatt ma kienu ħadu insulina qabel

treatment-naive adult patients
pazjenti adulti li ma esperjenzawx il-kura

insulin-naive patients n = 78
pazjenti li qatt ma ħadu insulina n = 78

classic i: infliximab naive patients
classic i: pazjenti li qatt ma ħadu infliximab

antiretroviral treatment naive adult patients
pazjenti adulti li qatt qabel ma ħadu kura antiretrovirali

not insulin-naive patients n = 97
pazjenti li diġà ħadu insulina n = 97

cd study i: infliximab naive patients
studju cd i: pazjenti li qatt ma ħadu infliximab

patients previously insulin naive or on basal isnulin
pazjenti li qatt ma ħadu insulina qabel jew li qegħdin fuq l-insulina tal-bażi

dosing for nucleoside naive paediatric patients aged 2 to < 18 years
dożaġġ għal pazjenti pedjatriċi li qatt ma ħadu nucleoside qabel li għandhom bejn sentejn sa < 18--il sena

the clinical development of duotrav included both patients naive and on therapy.
l-iżvilupp kliniku ta’ duotrav kien jinkludi kemm pazjenti ġodda għat-terapija kif ukoll pazjenti fuq it-terapija.

emerging genotypic entecavir resistance through year 5, nucleoside-naive studies
reżistenza Ġenotipika Ġdida għal entecavir sa sena 5, studji dwar pazjenti li qatt ma Ħadu nukleoside

emerging genotypic entecavir resistance through year 5, nucleoside-naive studies a
11 reżistenza Ġenotipika Ġdida għal entecavir sa sena 5, studji dwar pazjenti li qatt ma Ħadu nukleoside a

pharmacodynamic effects viramune has been evaluated in both treatment naive and treatment experienced patients.
effetti farmakodinamiċi viramune ġie valorizzat kemm fuq pazjenti inkonsapevoli mit- trattament kif ukoll fuq pazjenti b’ esperjenza ta 'trattament.

patients exposed only to antiretrovirals in utero or intrapartum were considered treatment-naive.
il- pazjenti esposti għal antiretrovirali in utero jew intrapartum kienu kkunsidrati bħala li qatt ma kienu kkurati fil-passat.